A

An IgG3 switch variant of rituximab mediates enhanced complement‐dependent cytotoxicity against tumour cells with low CD 20 expression levels

British Journal of Haematology

Authors 0

  1. Author list not loaded yet.

Cited by 1 stored of 26

1 result

References 0